284 related articles for article (PubMed ID: 28482102)
1. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.
Sakurai R; Montero-Odasso M
J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1676-1682. PubMed ID: 28482102
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotype and physical function among older people with mild cognitive impairment.
Doi T; Shimada H; Makizako H; Tsutsumimoto K; Uemura K; Suzuki T
Geriatr Gerontol Int; 2015 Apr; 15(4):422-7. PubMed ID: 24730603
[TBL] [Abstract][Full Text] [Related]
3. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG
J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476
[TBL] [Abstract][Full Text] [Related]
4. Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.
Liew TM
Aust N Z J Psychiatry; 2022 Dec; 56(12):1664-1675. PubMed ID: 35229693
[TBL] [Abstract][Full Text] [Related]
5. Sex Difference in the Association of APOE4 with Memory Decline in Mild Cognitive Impairment.
Wang X; Zhou W; Ye T; Lin X; Zhang J;
J Alzheimers Dis; 2019; 69(4):1161-1169. PubMed ID: 31127771
[TBL] [Abstract][Full Text] [Related]
6. Overlap Between Apolipoprotein Eε4 Allele and Slowing Gait Results in Cognitive Impairment.
Sakurai R; Watanabe Y; Osuka Y; Taniguchi Y; Kawai H; Kim H; Kitamura A; Inagaki H; Montero-Odasso M; Awata S; Shinkai S
Front Aging Neurosci; 2019; 11():247. PubMed ID: 31572165
[No Abstract] [Full Text] [Related]
7. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E allele 4 effects on Single-Subject Gray Matter Networks in Mild Cognitive Impairment.
Sanabria-Diaz G; Demonet JF; Rodriguez-Herreros B; Draganski B; Kherif F; Melie-Garcia L
Neuroimage Clin; 2021; 32():102799. PubMed ID: 34469849
[TBL] [Abstract][Full Text] [Related]
9. Gait Variability Can Predict the Risk of Cognitive Decline in Cognitively Normal Older People.
Byun S; Han JW; Kim TH; Kim K; Kim TH; Park JY; Suh SW; Seo JY; So Y; Lee KH; Lee JR; Jeong H; Jeong HG; Han K; Hong JW; Kim KW
Dement Geriatr Cogn Disord; 2018; 45(5-6):251-261. PubMed ID: 29953979
[TBL] [Abstract][Full Text] [Related]
10. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
Montagne A; Nation DA; Sagare AP; Barisano G; Sweeney MD; Chakhoyan A; Pachicano M; Joe E; Nelson AR; D'Orazio LM; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Reiman EM; Caselli RJ; Chui HC; Tcw J; Chen Y; Pa J; Conti PS; Law M; Toga AW; Zlokovic BV
Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954
[TBL] [Abstract][Full Text] [Related]
11. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration.
Franzmeier N; Suárez-Calvet M; Frontzkowski L; Moore A; Hohman TJ; Morenas-Rodriguez E; Nuscher B; Shaw L; Trojanowski JQ; Dichgans M; Kleinberger G; Haass C; Ewers M;
Mol Neurodegener; 2020 Oct; 15(1):57. PubMed ID: 33032659
[TBL] [Abstract][Full Text] [Related]
12. Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment.
An H; Son SJ; Cho S; Cho EY; Choi B; Kim SY;
Int Psychogeriatr; 2016 May; 28(5):769-78. PubMed ID: 26674540
[TBL] [Abstract][Full Text] [Related]
13. Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
Sokolow S; Li X; Chen L; Taylor KD; Rotter JI; Rissman RA; Aisen PS; Apostolova LG
J Alzheimers Dis; 2017; 56(1):229-237. PubMed ID: 27911294
[TBL] [Abstract][Full Text] [Related]
14. Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals.
Olofsson JK; Larsson M; Roa C; Wilson DA; Jonsson Laukka E
Behav Genet; 2020 Jan; 50(1):3-13. PubMed ID: 31760549
[TBL] [Abstract][Full Text] [Related]
15. Gait Characteristics and Cognitive Decline: A Longitudinal Population-Based Study.
Jayakody O; Breslin M; Srikanth VK; Callisaya ML
J Alzheimers Dis; 2019; 71(s1):S5-S14. PubMed ID: 30958358
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
Blautzik J; Kotz S; Brendel M; Sauerbeck J; Vettermann F; Winter Y; Bartenstein P; Ishii K; Rominger A;
J Alzheimers Dis; 2018; 65(3):781-791. PubMed ID: 28697560
[TBL] [Abstract][Full Text] [Related]
17. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.
Qiu WQ; Zhu H; Dean M; Liu Z; Vu L; Fan G; Li H; Mwamburi M; Steffens DC; Au R
Int J Geriatr Psychiatry; 2016 Mar; 31(3):316-22. PubMed ID: 26250797
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E alleles in Cuban patients with mild cognitive impairment.
Suárez VM; Fernández Y; López Edel C; Clarke DH; Bobes MA; Riverón AM; López-Cánovas L
Am J Alzheimers Dis Other Demen; 2014 May; 29(3):236-41. PubMed ID: 24370622
[TBL] [Abstract][Full Text] [Related]
20. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
